Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction

European Heart Journal

Volumn 23, Issue 5, 2002, Pages 399-404

  Wong, C K ^a,b   French, J K ^a   Andrews, J ^a   Frey, M J ^c   Adgey, A A J ^d   Aylward, P E ^e   White, H D ^a  

^a GREEN LANE HOSPITAL   (New Zealand)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c Heart Centre of Saratosa   (United States)

^d ROYAL VICTORIA HOSPITAL   (United Kingdom)

^e Flinders Cardiovascular Centre   (Australia)

Author keywords

Myocardial salvage; QRS score; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEPARIN; HIRULOG; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; DOUBLE BLIND PROCEDURE; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT DEPRESSION; T WAVE;

ANGIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; THROMBOLYTIC THERAPY;

EID: 0036522221     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.2795     Document Type: Article

References (29)

1. White HD, Van de Werf FJ. Thrombolysis for acute myocardial infarction. Circulation 1998; 97: 1632-46.
2. Fibrinolytic Therapy Trialists' Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
3. French JK, Williams BF, Hart HH et al. Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. Br Med J 1996; 312: 1637-41.
4. The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase or both on coronary artery patency, ventricular function and survival after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
5. Startt-Selvester RH. Myocardial infarction. In Macfarlane PW, Lavis TDV eds. Comprehensive Electrocardiology: Theory and Practice in Health and Disease. London: Pergamon, 1989: 565-629.
6. Hinohara T, Hindman NB, White RD, Ideker RE, Wagner GS. Quantitative QRS criteria for diagnosing and sizing myocardial infarcts. Am J Cardiol 1984; 53: 875-8.
7. Hindman NB, Schocken DD, Widmann M. Evaluation of a QRS scoring system for estimating myocardial infarct size. Am J Cardiol 1985; 55: 1485-90.
8. Ideker RE, Wagner GS, Ruth WK et al. Evaluation of a QRS scoring system for estimating myocardial infarct size: Correlation with quantitative anatomic findings for anterior infarcts. J Cardiol 1982; 49: 1604-14.
9. Roark SF, Ideker RE, Wagner GS et al. Evaluation of a QRS scoring system for estimating myocardial infarct size: Correlation with quantitative anatomic findings for inferior infarcts. Am J Cardiol 1983; 51: 382-9.
10. Sevilla DC, Wagner NB, White RD. Anatomic validation of electrocardiographic estimation of the size of acute or healed myocardial infarcts. Am J Cardiol 1990; 65: 1301-7.
11. Haisty WK, Pahlm O, Wagner NB, Pope JE, Wagner GS. Performance of the automated complete Selvester QRS scoring system in normal subjects and patients with single or multiple myocardial infarctions. J Am Coll Cardiol 1992; 19: 341-6.
12. Jeurgens CP, Fernandes C, Hasche E et al. Electrocardiographic measurement of infarct size after thrombolytic therapy. J Am Coll Cardiol 1996; 27: 617-24.
13. White HD, Aylward PE, Frey MJ et al. on behalf of the Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators. Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Circulation 1997; 96: 2155-61.
14. Wong CK, French JK, Aylward PE, Frey MJ, Adgey AAJ, White HD. Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction. Am J Cardiol 1999; 83: 164-8.
15. Chesebro JH, Knatterud G, Roberts R, et al. Thrombolysis in Myocardial infarction (TIMI) trial, phase 1: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 1987; 76: 142-54.
16. Rentrop KP, Cohen M, Blanke H, Philips RA. Changes in collateral channel filling immediately after controlled coronary artery occlusion by an angioplasty balloon in human subjects. J Am Coll Cardiol 1985; 5: 587-92.
17. Reimer KA, Lowe JE, Rasmussen MM, Jenning RB. The wave-front phenomenon of ischemic cell death. I. Myocardial infarct size vs duration of coronary occlusion in dogs. Circulation 1977; 786-94.
18. Reimer KA, Jennings RB, Cobb FR et al. Animal models for protecting ischemic myocardium: Results of the NHLBI cooperative study: Comparisons of the unconscious and conscious dog models. Circ Res 1985; 56: 651-65.
19. Hackett D, Davies G, Chierchia G, Maseri A. Intermittent coronary occlusion in acute myocardial infarction: Value of combined thrombolytic and vasodilator therapy. N Engl J Med 1987; 317: 1055-9.
20. Kannel WB. Lipids, diabetes and coronary heart disease: Insights from the Framingham study. Am Heart J 1985; 110: 1100-7.
21. Kloner RA, Shook T, Przyklenk K et al. Previous angina alters in-hospital outcome in TIMI 4: A clinical correlate to preconditioning? Circulation 1995; 91: 37-45.
22. Ottani F, Galvani M, Ferrini D et al. Prodromal angina limits infarct size: A role for ischemic preconditioning. Circulation 1995; 91: 291-7.
23. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996; 334: 7-12.
24. Christian TF, Schwartz RS, Gibbons RJ. Determinants of infarct size in reperfusion therapy for acute myocardial infarction. Circulation 1992; 86: 81-90.
25. Chareonthaitawee P, Gibbons RJ, Roberts RS, Christian TF, Burns R, Yusuf S, for the CORE Investigators. The impact of time to thrombolytic treatment on outcome in patients with acute myocardial infarction. Heart 2000; 84: 142-8.
26. Boersma E, Mass ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: Reappraisal of the golden hour. Lancet 1996; 348: 771-5.
27. Langer A, Goodman SG, Topol EJ et al. for the LATE Study Investigators. Late Assessment of Thrombolytic Efficacy (LATE) study: Prognosis in patients with non-Q wave myocardial infarction. J Am Coll Cardiol 1996; 27: 1327-32.
28. Andrews J, French JK, Manda SO, White HD. New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST elevation myocardial infarction. Eur Heart J 2000; 21: 647-53.
29. Bar FW, Volder PG, Hoppener P, Vermeer F, Meyer J, Wellens HJ. Development of ST-segment elevation and Q- and R-wave changes in acute myocardial infarction and the influence of thrombolytic therapy. Am J Cardiol 1996; 77: 337-43.